Vital Healthcare talks up unitholder returns
Vital executives upbeat at AGM after a strong result.
AdvertisementAdvertise with NZME.
Latest fromCompanies
Fare dinkum: $25 Jetstar sale on thousands of seats
Airline says it has 10,000 fares at $25 from February next year
Fran O'Sullivan: SkyCity looks to luck of the Irish for rocky road ahead
Casino firm's new boss has to deal with uncertainty after executive departures.
Jarden Brief: Wall Street kicks off week on a high
Jarden's daily update on the biggest market moves and shakes.
The story behind the three high-profile SkyCity resignations
What really happened at SkyCity?
Market close: NZX continues rise, SkyCity falls on exec departures
The New Zealand sharemarket continued its merry way.
Cavalier finds another buyer for its Auckland property
Original sale fell through last week.
Row erupts between cannabis firm Puro and two former directors
Allegations fly as cannabis firm fund raises.
Rich pickings: Is Zuru after your brand?
Zuru's Nick Mowbray and MONDAY haircare's Jaimee Lupton talk about the war of the brands.
$38.8m Nido cost $44.6m to build: construction company liquidated
Kumar rejected bankers' advice to think small, saying "I'm running out of time"
Market close: F&P Healthcare climbing back, Mainfreight hits $60 again
The New Zealand sharemarket finished an eventful week with a small gain.
Qantas cuts transtasman flights as MIQ spots fill up
Australia-bound passengers may also be hit by cancellations as capacity is cut.
Lex: Hedge funds: choose your fighter
Diverging expectations offer opportunities for the likes of Dan Loeb and Bill Ackman.
Jarden Brief: Vaccine enthusiasm cools off on Wall Street
Jarden's daily update on the latest market moves and shakes.
Continuous Disclosure: Kiwis line up for Airbnb, Fletcher's comeback
Kiwi investors are expected to line up for a slice of Airbnb when it floats on Nasdaq.
Covid party pooper for airlines: How Qantas will celebrate turning 100
The pandemic arrived as some airlines were planning milestone flights and events.
Market close: Mainfreight, Xero make strong gains
While the two growth stocks hogged the limelight, the S&P/NZX 50 Index had a flat day.
Synlait completes trifecta with capital raise
Synlait's successful capital raising comes as the company resolves a number of issues.
'A significant step': Major airline resumes flights in New Zealand
Quarantine requirements in NZ and Hong Kong put the brakes on leisure travel.
Air NZ's Dreamliner engine problems - the final ruling
In one case the broken blade showered the aircraft's fuselage with shredded metal.
Infratil earnings buoyed by Vodafone, CDC contributions
Acquisitions lead to jump in manager incentive fees.
Rebuilding Air NZ's exec: Back for the future with new CFO
New recruit has recently been involved in sale of NZ retirement village firm for $1.3b
Jarden Brief: Embattled Revlon shares surge 30 per cent
Jarden's daily update on the latest market moves and shakes.
'I've lost four weeks of my life': Fletcher boss on his month in quarantine
"I've lost four weeks of my life now in quarantine." - Ross Taylor.
Straker shares explode on IBM deal
Big Blue equals big gains, with headcount increasing by a third. A snipe with analysts.
Market close: NZ shares rise, Mainfreight touches milestone
The S&P/NZX 50 Index closed 53.24 points or 0.42 per cent ahead.
Mainfreight laps up local demand, shares near $60 each
Mainfreight's six month financial results defied gloomy pandemic economic forecasts.
Kiwi health tech firm poised to leap-frog competitors
Coveted European certification will help elbow past rivals in $200b global market.
Global stock rally slows, but optimism over vaccine remains high
The market has calmed since yesterday's excitement.
Market close: Travel and leisure stocks rise on Covid vaccine news
The New Zealand sharemarket had a wild ride.
Fletcher boss optimistic about Ihumātao solution
"We are waiting to hear back from Labour about the resolution."
NZME lifts earnings guidance, refunds staff, plans dividend
Improved forecast driven by better than expected revenue recovery from Covid crisis.